Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization
Modern Pathology · 2026-11 · 39 (11) · 101084
DOI: 10.1016/j.modpat.2026.101084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2026-11. Verfasst von Yuxiu Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Interferon Regulatory Factors, Gene Rearrangement, Lymphoma, Large B-Cell, Diffuse, Biomarkers, Tumor. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: yidoctor@163.com.
- Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: wangchaofu@126.com.
- Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: hou.yingyong@zs-hospital.sh.cn.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhang, Y., Li, A., Li, Y., Zhang, L., Zhang, L., Li, L., Huang, Y., Du, L., Huang, J., Dong, L., Xu, H., Ouyang, B., Yi, H., Wang, C., & Hou, Y. (2026). Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization. Modern Pathology, 39(11), 101084. https://doi.org/10.1016/j.modpat.2026.101084
Vancouver
Zhang Y, Li A, Li Y, Zhang L, Zhang L, Li L, et al. Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization. Modern Pathology. 2026;39(11):101084. doi:10.1016/j.modpat.2026.101084
BibTeX
@article{Zhang2026,
author = {Zhang, Yuxiu and Li, Anqi and Li, Yimin and Zhang, Lei and Zhang, Lili and Li, Lei and Huang, Yufeng and Du, Linlin and Huang, Jie and Dong, Lei and Xu, Haimin and Ouyang, Binshen and Yi, Hongmei and Wang, Chaofu and Hou, Yingyong},
title = {Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization},
journal = {Modern Pathology},
year = {2026},
volume = {39},
number = {11},
pages = {101084},
doi = {10.1016/j.modpat.2026.101084}
}
EUVIMED